Broadcrest Asset Management’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-250,000
Closed -$16M 7
2023
Q2
$16M Sell
250,000
-100,000
-29% -$5.69M 13.78% 4
2023
Q1
$18.7M Buy
350,000
+50,000
+17% +$2.9M 16.27% 2
2022
Q4
$16.1M Buy
300,000
+50,000
+20% +$2.58M 17.53% 2
2022
Q3
$11.5M Buy
250,000
+50,000
+25% +$2.71M 13.15% 3
2022
Q2
$11M Sell
200,000
-90,500
-31% -$5.83M 11.51% 4
2022
Q1
$19.9M Buy
290,500
+81,340
+39% +$5.79M 16.54% 3
2021
Q4
$16.5M Buy
+209,160
New +$17.5M 11.97% 5

Other funds holding ENOV

Broadcrest Asset Management's ENOV Position: Q3 2023 in Review

Broadcrest Asset Management sold out of Enovis (ENOV) in Q3 2023, closing a stake of 250,000 shares — an estimated $16M sold.

Broadcrest Asset Management first reported a position in ENOV in Q4 2021 and held it in 7 quarters. The position peaked at $19.9M in Q1 2022. 267 funds tracked by Wall St. Rank hold ENOV as of Q3 2023.

  • Broadcrest Asset Management reported no remaining Enovis position as of Q3 2023 after selling out during the quarter.
  • Broadcrest Asset Management sold 250,000 Enovis shares in Q3 2023, an estimated $16M.
  • Broadcrest Asset Management first reported a position in Enovis in Q4 2021 and held it in 7 quarters.
  • Broadcrest Asset Management's Enovis position peaked at $19.9M in Q1 2022.
  • 267 funds tracked by Wall St. Rank held Enovis as of Q3 2023.

Based on Broadcrest Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.